Penile Length Restoration in Men with Type II Diabetes

Overview

About this study

The purpose of this study is to assess penile length pre- and post-completion of RestoreX® traction therapy compared to control groups (no treatment) among men with type II diabetes.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

Men with DM, type 2.
>18 years old.

Exclusion Criteria:

Any evidence of end-organ failure attributed to DM (assessed based on medical history / patient history alone)
Loss of fingers / toes.
CKD Stage IV or greater.
Retinopathy
Myocardial infarction.
Cerebrovascular accident.
Indwelling penile prosthesis or prior history of penile prosthesis.
Peyronie’s disease at baseline.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location	Status
Rochester, Minn. Mayo Clinic principal investigator Matthew Ziegelmann, M.D.	Closed for enrollment

Mayo Clinic Location

Status

Rochester, Minn.

Mayo Clinic principal investigator

Matthew Ziegelmann, M.D.

Closed for enrollment

More information

Publications

Publications are currently not available

Clinical Trials